Expenditure and resource utilisation for cervical screening in Australia

Table 2 Model outcomes in Australia 2010, compared against latest observed data

	Model predicted	Latest observed data^†
Number of cytology performed
20-69 years	2 million	2 million
All ages	2.1 million	2.1 million
Number of low-grade cytology abnormalities detected in women 20–69 years	84,600	78,510^††
Number of high-grade cytology abnormalities detected in women 20–69 years	27,700	28,491^††
Number of women with abnormal cytology with a follow-up histological evaluation	33,200	38,859^††
High-grade histology rate per 1,000 women screened	7.4	8.4
Age-standardised rate of cervical cancer incidence per 100,000 women^‡
20-69 years	8.9	9.3^‡‡
All ages	6.6	7^‡‡
Age-standardised rate of cervical cancer incidence per 100,000 women^‡
20-69 years	2.1	1.9^‡‡
All ages	1.8	1.8^‡‡

^† Data obtained from Cervical Screening in Australia 2009–2010 report [5].
^†† At the time of writing the latest available data was in 2009.
^‡ Age-standardised to 2001 Australian population.
^‡‡ At the time of writing the latest available data for cancer incidence was in 2008 and for cancer mortality was 2007.

ISSN: 1472-6963